News
Research Now Appoints Michael Bigby as Chief Technology Officer...
article.wn.com
(Source: Research Now Ltd) Co-founder of BlueKai, former Sr. Director at Yahoo! and CTO at Extole joins Research Now's executive team ...
The Vineyard Gazette - Martha's Vineyard News | Aquinnah Town Column:...
vineyardgazette.com
Autumn has arrived! The temperatures are in the 40s over night and in 50s and 60s during the day. This is the last hurrah for most seasonal businesses. A...
Brodalumab approval recommended, despite possible suicide signal |...
www.mdedge.com
An FDA advisory committee has supported approval of the monoclonal antibody brodalumab for treating moderate to severe plaque psoriasis.
FDA Panel Backs New Psoriasis Drug
www.webmd.com
"If you concentrate on risk-benefit compared to almost everything else we have available, the drug looks pretty good," said Michael Bigby, MD, the panel's chairman. Ustekinumab works by targeting inflammatory chemicals called ...
sorted by relevance / date